Enveric Biosciences, Inc.
Enveric Biosciences, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for mental health and neurological disorders. Founded in 2019, the company has quickly established itself within the biopharmaceutical industry, particularly in the realm of psychedelic medicine and cannabinoid-based treatments. Enveric's core offerings include a range of proprietary compounds designed to enhance patient outcomes in mental health care. Their unique approach combines advanced scientific research with a commitment to patient-centric solutions, setting them apart in a competitive market. With a strong emphasis on clinical development, Enveric has achieved significant milestones, positioning itself as a leader in the emerging field of psychedelic therapeutics.
DitchCarbon Score
How does Enveric Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Enveric Biosciences, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Enveric Biosciences, Inc.'s reported carbon emissions
Enveric Biosciences, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives reported, it is unclear how Enveric Biosciences is addressing its carbon footprint or contributing to climate action within the biotechnology sector. The lack of data may suggest an opportunity for the company to develop and communicate its climate commitments more effectively in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Enveric Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
